Category
Blood disorders
Sub Category
Hemophilia
Study Name
Biogen Idec 997HA306: An Open Label, Multicenter, Evaluation of the Safety and Efficacy of Recombinant Coagulatiion Factor Vlll Fc Fusion Protein (rFVlllFc;BllB031) in the Prevention and Treatment of Bleeding in Previously Untreated Patients with Severe Hemophilia A
Principal Investigator
Roshni Kulkarni, MD
Study Information
Contact for Questions
517-364-5440

Site view: at a glance